1 Abstract Triple-Negative Breast Cancer (TNBC) is a rare cancer, characterized by high
metastatic potential and poor prognosis, and has limited treatment options compared to …

Estrogen receptor α (ERα) is an important biomarker in breast cancer diagnosis and
treatment. Sensitive and accurate detection of ERα protein expression is crucial in guiding …

In the last decade, the analysis of the medical images has evolved significantly, applications
and tools capable to extract quantitative characteristics of the images beyond the …

Targeted delivery and precise release of toxins is a prospective strategy for the treatment of
triple-negative breast cancer (TNBC), yet the flexibility to incorporate both properties …

Many similar characteristics in human and dog cancers including, spontaneous
development, clinical presentation, tumor heterogeneity, disease progression, and response …

Purpose: Anti-EGFR antibodies show limited response in breast cancer, partly due to
activation of compensatory pathways. Furthermore, despite the clinical success of cyclin …

Background This study aimed to demonstrate CXCL8 expression in TNBC tissues and cells,
and elucidate the functional mechanism of CXCL8 in paclitaxel (PTX)-resistant TNBC …

Radiotherapy demonstrates a synergistic effect with immunotherapy by inducing a
transformation of “immune cold” tumors into “immune hot” tumors in triple negative breast …

Breast cancer (BC) is the leading cause of cancer-related death in women worldwide. Triple
negative breast cancer (TNBC) is the most aggressive form of BC being with the worst …

Introduction The design of delivery tools that efficiently transport drugs into cells remains a
major challenge in drug development for most pathological conditions. Triple-negative …